Aim Continuous subcutaneous insulin infusion (CSII) can improve glycaemic control and dietary flexibility compared with conventional insulin therapies. There is little information on whether users are utilising this increased dietary flexibility, and whether dietary quality is affected. Methods A pre-post observational study was undertaken in 28 children and adolescents with type 1 diabetes commencing CSII. Meal pattern and dietary composition was examined from 3-day food diaries completed before and 3-6 months after CSII commencement. Participants completed the Diabetes-Specific Quality of Life for Youth Short Form, and body mass index z-score, and glycated haemoglobin were measured. A second posttest was undertaken at 18 months with those...
Objective: Continuous subcutaneous insulin infusion (CSII) and multiple daily insulin injections (MD...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
BackgroundIn 2017, more than 1.1 million children were living with type 1 diabetes mellitus (T1DM) g...
Objective To evaluate whether insulin pump therapy [continuous subcutaneous insulin infusion (CSII)]...
OBJECTIVE: This study analyzed the changes in insulin requirement in the transition from multiple da...
Carbohydrate counting (CHC) in combination with nutritional education has been used to optimize the ...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Evidence suggests continuous subcutaneous insulin infusion (CSII) is an effective method of achievin...
Continuous Subcutaneous Insulin Infusion (CSII) represents the latest technology in insulin delivery...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Introduction: An increased number of adolescents with Type 1 Diabetes Mellitus are choosing CSII to ...
AIMS/HYPOTHESIS: To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-...
BackgroundIn 2017, more than 1.1 million children were living with type 1 diabetes mellitus (T1DM) g...
Objective: Continuous subcutaneous insulin infusion (CSII) and multiple daily insulin injections (MD...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
BackgroundIn 2017, more than 1.1 million children were living with type 1 diabetes mellitus (T1DM) g...
Objective To evaluate whether insulin pump therapy [continuous subcutaneous insulin infusion (CSII)]...
OBJECTIVE: This study analyzed the changes in insulin requirement in the transition from multiple da...
Carbohydrate counting (CHC) in combination with nutritional education has been used to optimize the ...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Evidence suggests continuous subcutaneous insulin infusion (CSII) is an effective method of achievin...
Continuous Subcutaneous Insulin Infusion (CSII) represents the latest technology in insulin delivery...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
Introduction: An increased number of adolescents with Type 1 Diabetes Mellitus are choosing CSII to ...
AIMS/HYPOTHESIS: To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-...
BackgroundIn 2017, more than 1.1 million children were living with type 1 diabetes mellitus (T1DM) g...
Objective: Continuous subcutaneous insulin infusion (CSII) and multiple daily insulin injections (MD...
Aims/hypothesis To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-l...
BackgroundIn 2017, more than 1.1 million children were living with type 1 diabetes mellitus (T1DM) g...